课题基金 / 基金详情

Lymphatic regulation of lymph node function in lupus

Lymphatic regulation of lymph node function in lupus
狼疮淋巴结功能的淋巴调节
批准号:
10587191
负责人:
Theresa T. Lu
金额:
$55.6万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
未结题
起止时间:
2010-02-01 至 2028-01-31

项目摘要

项目成果

Theresa T. Lu的其他基金

相似基金

相关文献

中文摘要
翻译
系统性红斑狼疮(SLE)患者是光敏性的,表现为皮肤增厚, 对紫外线辐射(UVR)敏感,即使暴露在阳光下也会导致 炎症性皮肤病变的发展。然而,在皮肤之外,UVR暴露也会引发全身性疾病。 疾病爆发,循环自身抗体增加,终末器官进一步损伤。的机制 在皮肤上的UVR暴露可导致全身性自身免疫的爆发尚不清楚。我们 长期目标是阐明光敏性与系统性疾病发作之间的联系机制。皮肤 通过淋巴管与免疫系统沟通,淋巴管既用于从组织中除去组织液, 皮肤并带来抗原和介质来调节引流淋巴结的免疫功能。损害 淋巴流动导致皮肤炎症增加和延长,并改变到达淋巴的信号 结,导致长期产生自身抗体。两种皮肤中淋巴流动的重要性 和淋巴结调节使我们检查SLE的淋巴流动功能。我们有证据表明 在人SLE和多种小鼠模型中受损的淋巴流以及在人SLE和多种小鼠模型中改善淋巴流 SLE模型降低皮肤光敏性和引流淋巴结浆母细胞反应。我们的目标是 建议是了解淋巴流动调节引流淋巴结免疫的机制, 狼疮样疾病的反应。我们的初步数据表明,改善淋巴流动增加淋巴 结成纤维细胞网状细胞(FRC)表达CCL 2,驱动FRC-单核细胞-浆母细胞轴, 限制了浆母细胞的存活。改善淋巴流量也下调皮肤干扰素-I(IFN-I)刺激的 基因表达和FRC CCL 2的上调依赖于NADPH氧化酶的NOX 2亚基。 另外,改善淋巴流动还上调了FRC中IMP 2的表达,IMP 2是一种RNA结合蛋白, 检测N6-甲基腺苷RNA修饰并稳定CCL 2 mRNA,调节T细胞 在淋巴结中积聚。这些数据提出了以下假设:改善淋巴流动 减少IFN-I信号传导,上调FRC NOX 2介导的活性氧簇产生,从而驱动细胞增殖 IMP 2介导的FRC改变程序。所产生的FRC CCL 2上调调节单核细胞和巨噬细胞。 调节淋巴结中的T细胞功能,限制B细胞应答。我们的目标是1)描绘 IFN-I和Nox 2在调节FRC CCL 2中的关系,2)了解IFN-I和Nox 2的贡献程度, IMP 2与淋巴细胞驱动的FRC表型改变的关系,以及3)了解淋巴细胞- 驱动的FRC调节降低了B细胞应答。这项提案将帮助我们了解淋巴功能 有助于狼疮样疾病,并描述了FRC调节和塑造淋巴的机制 节点功能,铺平了道路,以更好地了解光敏性和 自身免疫
英文摘要
Patients with systemic lupus erythematosus (SLE) are photosensitive, demonstrating an increased skin sensitivity to ultraviolet radiation (UVR) whereby even ambient exposure to sunlight can result in the development of inflammatory skin lesions. Beyond the skin, however, UVR exposure can also trigger systemic disease flares, with increased circulating autoantibodies and further injury of end organs. The mechanisms by which UVR exposure at the skin can lead to flares of systemic autoimmunity are not well understood. Our long-term goal is to delineate the mechanisms that connect photosensitivity with systemic disease flares. Skin communicates with the immune system via lymphatic vessels which serve both to remove interstitial fluid from skin and bring antigens and mediators to regulate draining lymph node immune function. Compromised lymphatic flow results in increased and prolonged skin inflammation and alters the signals that reach the lymph nodes, resulting in autoantibody generation over the long term. The importance of lymphatic flow in both skin and lymph node regulation led us to examine lymphatic flow function in SLE. We show evidence of compromised lymphatic flow in human SLE and multiple mouse models and that improving lymphatic flow in SLE models reduces skin photosensitivity and draining lymph node plasmablast responses. Our goal with this proposal is to understand the mechanisms by which lymphatic flow regulates draining lymph node immune responses in lupus-like disease. We show preliminary data that improving lymphatic flow increases lymph node fibroblastic reticular cell (FRC) expression of CCL2, driving the FRC-monocyte-plasmablast axis that limits plasmablast survival. Improving lymphatic flow also downregulated skin interferon-I (IFN-I)-stimulated gene expression and upregulated FRC CCL2 was dependent on the NOX2 subunit of NADPH oxidase. Improving lymphatic flow additionally upregulated FRC expression of IMP2, an RNA binding protein that detects N6-methyladenosine RNA modifications and stabilizes CCL2 mRNA, and regulatory T cell accumulation in lymph nodes. These data suggest the following hypothesis: Improving lymphatic flow reduces IFN-I signaling, upregulating FRC NOX2-mediated reactive oxygen species generation that drives an IMP2-mediated program of FRC alterations. The resulting FRC CCL2 upregulation modulates monocyte and regulatory T cell function in lymph nodes, limiting B cell responses. Our aims are to 1) delineate the relationship between IFN-I and Nox2 in regulating FRC CCL2, 2) Understand the extent of contributions of IMP2 to lymphatic-driven FRC phenotypic alterations, and 3) understand the mechanisms by which lymphatic- driven FRC regulation reduces B cell responses. The proposal will help us understand how lymphatic function contributes to lupus-like disease and delineate mechanisms by which FRCs are regulated and shape lymph node function, paving the way to better understanding the relationship between photosensitivity and autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diversity supplement: Lymphatic regulation of lymph node function in lupus
  • 批准号:
    10794867
  • 项目类别:
  • 资助金额:
    $7.04万
  • 财政年份:
    2023
  • 负责人:
    Theresa T. Lu
  • 依托单位:
Skin-lymph node axis in SLE
  • 批准号:
    10666573
  • 项目类别:
  • 资助金额:
    $19.34万
  • 财政年份:
    2022
  • 负责人:
    Theresa T. Lu
  • 依托单位:
Skin-lymph node axis in SLE
  • 批准号:
    10510072
  • 项目类别:
  • 资助金额:
    $25.26万
  • 财政年份:
    2022
  • 负责人:
    Theresa T. Lu
  • 依托单位:
Vascular Quiescence and Stabilization in Immunity
  • 批准号:
    8213586
  • 项目类别:
  • 资助金额:
    $43.44万
  • 财政年份:
    2010
  • 负责人:
    Theresa T. Lu
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究